The NHS Cancer Programme at NHS England and NHS Improvement (NHSEI) are looking for innovations or new approaches that will increase the proportion of cancers that are diagnosed at stage one or two.
Programme: SBRI Healthcare
Award: Up to £4 million per project
Opens: 5th Apr 2022
Closes: 24th May 2022
The NHS Cancer Programme at NHS England and NHS Improvement (NHSEI) are looking for innovations or new approaches that will increase the proportion of cancers that are diagnosed at stage one or two. This includes innovations in the broadest possible sense, including behavioural interventions, software, or new models of care.
The competition is open to all types of innovations, including but not limited to, medical devices, in-vitro diagnostics, digital health solutions, behavioural interventions, software, artificial intelligence or new models of care. Innovations can be tumour specific or multi-cancer. Applications from multicancer innovations which could have a bigger impact on early diagnosis rates are particularly welcome.
Potential solutions to the challenge include strategies that support:
1. Identifying and testing asymptomatic patients who are most at risk. This includes:
2. Encouraging early symptomatic patients to self-assess and present to primary care or other appropriate services. This includes:
3. Assessment of risk in early symptomatic patients presenting to primary care. This includes:
The competition is open to single organisations (contracts are executed with individual legal entities) based in the UK or EU from the private, public and third sectors, including companies (large corporates and small and medium enterprises), charities, universities and NHS Foundation Trusts, as long as a strong implementation and commercial strategy is provided.
Organisations based outside the UK or EU with innovations in remit for this call can apply as subcontractors of a lead UK/EU based organisation or via a UK or EU subsidiary.
However, due to the nature of the projects supported, all proposals are expected to have partnerships in place with at least an NHS organisation, if they are not already led by one, and engage with appropriate suppliers to cover the expertise required for the successful delivery of the project.
Engagement with Cancer Alliances
and/or Academic Health Science Networks (AHSNs) is particularly encouraged.
Please note that only NHS clinical sites based in England are eligible.
The project will be 100% funded up to the value of £4 million (NET) for a maximum of 18 months in the first instance. Successful applicants will be selected by an open competition process and retain the intellectual property rights (IPR) generated from the project, with certain rights of use retained by the NHS.
Where appropriate, in-kind contributions and palatable, equitable and affordable innovation prices to the NHS should be considered.
Please ensure the proposed project deliverables could be reasonably achieved within the proposed contract duration, and all requested costs are justified.
Promising innovations may have the opportunity to bid for additional funding (for example scaling up implementation, supporting independent evaluations, etc.) at the end of the contract duration subject to an independent review process.
The innovations below are excluded from the call:
Book an appointment to speak to one of our advisors to discuss your eligibility to apply for this Grant Funding opportunity.